|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||2.22 - 2.28|
|52-week range||1.78 - 2.45|
|PE ratio (TTM)||0.90|
|Earnings date||27 Mar 2017 - 31 Mar 2017|
|Dividend & yield||N/A (N/A)|
|1y target est||15.55|
Categories: Yahoo FinanceGet free summary analysis ProPhase Labs, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of ProPhase Labs, Inc. – Mannatech, Incorporated, Reliv’ International, Inc., USANA Health Sciences, Inc., Nutraceutical International Corporation, Nature’s Sunshine Products, Inc., Oragenics, Inc., Cyanotech Corporation and XOMA Corporation (MTEX-US, ... Read more (Read more...)
DOYLESTOWN, Pa., Aug. 15, 2017-- ProPhase Labs, Inc., a diversified natural health medical science company, today announced that it intends to commence a tender offer to purchase up to 4,000,000 shares ...
DOYLESTOWN, Pa., Aug. 11, 2017-- ProPhase Labs, Inc. today reported its financial results for the three months and six months ended June 30, 2017. As previously announced, effective March 29, 2017 and ...